Search clinical trials for: closed-loop insulin delivery

Total 11457 results

Novo Nordisk A/S

Completed

Long Term Safety Trial to Compare Insulin Treatment With Preprandial Inhaled Human Insulin to s.c. Insulin Aspart Both Combined With NPH in Subjects With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Australia
Novo Nordisk A/S

Completed

Localisation of Potential Insulin Deposits in Normal Weight and Obese Diabetics Using 6 mm and 12 mm Long Needles

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1 | Delivery Systems

Denmark
Novo Nordisk A/S

Completed

Comparison of Two Pen Systems in Patients With Diabetes Treated With Insulin

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1 | Delivery Systems

Italy, United Kingdom, Austria, Netherlands, Germany
Novo Nordisk A/S

Completed

Observational Study to Evaluate Safety, Efficacy and Convenience of Using NovoMix® 30 FlexPen® in Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes | Delivery Systems

Indonesia
Novo Nordisk A/S

Completed

Observational Study of NovoPen® 4 on Treatment Satisfaction of Insulin Therapy in Type 1 or Type 2 Subjects With Diabetes Mellitus

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1 | Delivery Systems

China
Novo Nordisk A/S

Completed

Observational Study to Evaluate Safety and Efficacy of Insulin Therapy in Type 2 Diabetes Mellitus Subjects Failing on Oral Anti-diabetic Agents

Diabetes Mellitus, Type 2 | Diabetes

Indonesia
Novo Nordisk A/S

Completed

Observational Study to Assess the Efficacy and Safety of NovoRapid™ Flexpen™

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1 | Delivery Systems

Philippines
NantCell, Inc.

Completed

QUILT-2.019: A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic Cancer

Pancreatic Cancer | Adenocarcinoma of the Pancreas | Metastatic Pancreatic Cancer

United States
Novo Nordisk A/S

Completed

A Study of the Treatment of Type 2 Diabetes With an Insulin Infusion Pump

Diabetes Mellitus, Type 2 | Diabetes | Delivery Systems

United States
Novo Nordisk A/S

Completed

Comparison of Insulin Glargine Against Insulin Aspart Infused Under the Skin in Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes | Delivery Systems

Denmark
Massachusetts General Hospital

Unknown

Pharmacokinetic Comparison of Intradermal Versus Sub-cutaneous Insulin and Glucagon Delivery in Type 1 Diabetes

Type 1 Diabetes

United States
University of Missouri-Columbia

Completed

Pilot Study to Test Dietary Fat Delivery

Insulin Resistance

United States
Florida Atlantic University
Advanced Diabetes Treatment Centers; Global Infusions

Terminated

Effects of Pulsatile Insulin Delivery on Diabetic Neuropathy in Patients With Types 1 and 2 Diabetes Mellitus

Diabetes Mellitus, With Complications

United States
Florida Atlantic University
Advanced Diabetes Treatment Centers; Global Infusions

Terminated

Effects of Pulsatile IV Insulin Delivery on Diabetic Retinopathy in Patients With Types 1 and 2 Diabetes Mellitus

Diabetes Mellitus, With Complications

United States
Florida Atlantic University
Advanced Diabetes Treatment Centers; Global Infusions

Withdrawn

Effects of Pulsatile Intravenous Insulin Delivery on Hypoglycemic Unawareness

Hypoglycemia

United States
Florida Atlantic University
Advanced Diabetes Treatment Centers; Global Infusions

Withdrawn

Effects of Pulsatile Intravenous Insulin Delivery on Diabetic Neuropathy in pATIENTS (Pts) With Type 1 and Type 2 Diabetes

Diabetic Neuropathy

United States
Florida Atlantic University
Advanced Diabetes Treatment Centers

Terminated

Clinical Effects of Pulsatile Insulin Delivery on Cognitive Function- Phase 1

Diabetes Mellitus

United States
CeQur Corporation
International Diabetes Center at Park Nicollet

Completed

Study of PaQ™ (a Simple Patch on Insulin Delivery Device) in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Austria
CeQur Corporation

Completed

A Study to Assess Insulin Delivery With PaQ® in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Austria
CeQur Corporation

Terminated

A Prospective Observational Study to Assess Insulin Delivery With PaQ® in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Austria
Sansum Diabetes Research Institute
University of California, Santa Barbara

Completed

MPC Versus PID for Closed Loop Insulin Delivery

Type 1 Diabetes Mellitus

United States
St Vincent's Hospital Melbourne
Juvenile Diabetes Research Foundation; Medtronic

Completed

The Performance of an Artificial Pancreas at Home in People With Type 1 Diabetes

Type 1 Diabetes

Australia
University of Cambridge
Medical University of Graz; Profil Institut für Stoffwechselforschung GmbH

Completed

Closing the Loop in Adults With Sub-optimally Controlled Type 1 Diabetes Under Free Living Conditions (AP@home04)

Type 1 Diabetes

United Kingdom, Austria, Germany
Novo Nordisk A/S

Completed

Safety and Efficacy of Insulin NPH Compared to a New Insulin Formulation in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Brazil
Hvidovre University Hospital
University of Copenhagen; The Novo Nordic Foundation

Unknown

Treatment of Low Blood Sugar With Glucagon Among Patients With Type 1 Diabetes (GluST1)

Diabetes Mellitus, Type 1

Denmark
Insuline Medical Ltd.

Unknown

Evaluation of the Effects of Heating the Vicinity of the Insulin Delivery Site by the Experimental Device

Diabetes Mellitus

Israel
Sheba Medical Center

Unknown

Multiday Fully Closed Loop Insulin Delivery in Monitored Outpatient Conditions

To Demonstrate That the Closed Loop System Can be Used Safely Over a Few Consecutive Days. | To Assess Effectiveness in Maintaining Patients' Glucose Levels in the Target Range of 70 to 180 mg/dl, Measured by Blood Glucose Sensor. | To Evaluate the User Experience With a Closed Loop...

Israel
Centre for Fetal Programming, Denmark
National Institutes of Health (NIH); Danish Council for Independent Research; The Danish Council for Strategic Research and other collaborators

Completed

Impact of Fish Oil Supplementation in 3rd Trimester of Pregnancy on Maternal and Offspring Health

Metabolic Syndrome | Preterm Delivery | Atopy

Denmark
University of Cambridge
Diabetes UK

Completed

Closing the Loop in Adults With Type 1 Diabetes in the Home Setting

Type 1 Diabetes Mellitus

United Kingdom
Emory University
Thrasher Research Fund

Completed

Insulin Delivery Using Microneedles in Type 1 Diabetes

Type 1 Diabetes Mellitus

United States
CPEX Pharmaceuticals Inc.

Completed

Effects of Nasulin Versus Placebo on Blood Glucose Control in Patient Volunteers With Type 2 Diabetes Mellitus (CPEX-011)

Type 2 Diabetes

United States
Daniela Elleri
Cambridge University Hospitals NHS Foundation Trust

Unknown

Closing the Loop in Young Children With Type 1 Diabetes

Type 1 Diabetes

United Kingdom
Insuline Medical Ltd.

Completed

Evaluation of the Effects of Heating or Massaging or Vibrating at the Vicinity of the Insulin Delivery Site

Diabetes

Israel
University of Cambridge
Cambridge University Hospitals NHS Foundation Trust; European Commission

Completed

Closed Loop Glucose Control in Intensive Care Unit (CLASSIC)

Stress Hyperglycaemia

United Kingdom
Animas Corporation

Completed

Study Assessing an Insulin Pump-controlling Algorithm to Minimize Hypo and Hyper in Type 1 During CRC Setting

Type 1 Diabetes Mellitus

United States
Insuline Medical Ltd.

Suspended

Evaluation of the Effects of Heating the Vicinity of the Insulin Delivery Site by the InsuPatch Device During Daily Life

Diabetes
Becton, Dickinson and Company

Completed

Multi-day (3) In-patient Evaluation of Intradermal Versus Subcutaneous Basal and Bolus Insulin Infusion

Diabetes

Germany
University of Cambridge
Cambridge University Hospitals NHS Foundation Trust

Completed

Closing the Loop in Adolescents During Non-compliance Behaviours

Type 1 Diabetes

United Kingdom
University of Cambridge
Cambridge University Hospitals NHS Foundation Trust

Completed

Closing the Loop for 36 Hours in Adolescents With Type 1 Diabetes: Evaluation of Reduced Meal Bolusing

Type 1 Diabetes

United Kingdom
University of Cambridge
Cambridge University Hospitals NHS Foundation Trust

Completed

Automated Overnight Closed-loop Glucose Control in Young People With Type 1 Diabetes (APCam05)

Type 1 Diabetes

United Kingdom
Medical University of Graz

Completed

Integrating Insulin Delivery and Glucose Sensing in Subcutaneous Tissue for the Treatment of Type-1 Diabetic Patients

Type 1 Diabetes

Austria
Legacy Health System
Juvenile Diabetes Research Foundation; Oregon Health and Science University

Completed

Sensor-Augmented Insulin Delivery: Insulin Plus Glucagon Versus Insulin Alone

Type 1 Diabetes

United States
Medtronic Diabetes

Completed

Study Comparing Effectiveness of Intraperitoneal Insulin Administration to Subcutaneous Insulin Administration (MIP310)

Type 1 Diabetes

United States
University of Moron

Withdrawn

Safety and Efficacy of Arterial Delivery of Autologous Bone Marrow Cells in the Treatment of Insulin-Dependent Diabetes

Type 1 Diabetes Mellitus

Chile
Global Infusion and Aspiration Systems, LLC

Unknown

Effects of Intensive Bolus Intravenous Insulin Delivery on Metabolic Integrity in Type 1 and Type 2 Diabetes

Diabetes Mellitus | Metabolic Integrity

United States
NiliMedix

Completed

User Satisfaction Using the ADI Insulin Pump

Diabetes

Israel
Becton, Dickinson and Company

Completed

Study on the Effects on Blood Glucose Following Intradermal and Subcutaneous Dosing of Insulin in Diabetic Patients

Diabetes

Germany
University of Cambridge
Cambridge University Hospitals NHS Foundation Trust

Completed

Closing the Loop for 36 Hours in Adolescents With Type 1 Diabetes

Type 1 Diabetes

United Kingdom
Hadassah Medical Organization

Unknown

Effects of Heating Massaging Vibrating Vicinity of the Insulin Delivery Site

DIABETES

Israel
Altea Therapeutics

Completed

Transdermal Basal Insulin Patch Study in Type 1 Diabetes

Type 1 Diabetes

United States

Search clinical trials for: closed-loop insulin delivery

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Finland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations